Eosinophils cocultured with endothelial cells have increased survival and functional properties.
暂无分享,去创建一个
[1] A. Sheffer,et al. Synthesis and release of leukotriene C4 by human eosinophils. , 1987, Journal of immunology.
[2] A. Wardlaw,et al. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. , 1986, The Journal of clinical investigation.
[3] J. Dipersio,et al. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. , 1986, Journal of immunology.
[4] J. Gamble,et al. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. , 1986, The Journal of clinical investigation.
[5] H. Koeffler,et al. Recombinant human TNF induces production of granulocyte–monocyte colony-stimulating factor , 1986, Nature.
[6] C. Begley,et al. Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. , 1986, Blood.
[7] K. Austen,et al. Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. , 1985, Journal of immunology.
[8] S. Orkin,et al. Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis , 1985, Nature.
[9] A. Capron,et al. Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density. , 1984, Clinical and experimental immunology.
[10] W. Henderson,et al. Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products. , 1984, Immunology.
[11] E. Levine,et al. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. , 1983, Science.
[12] M. Vadas,et al. Maturation In Vivo of Schistosoma mansoni Schistosomula After Culture In Vitro with Granulocytes and Antibody , 1983, Infection and immunity.
[13] I. Olsson,et al. Altered density, metabolism and surface receptors of eosinophils in eosinophilia. , 1982, Immunology.
[14] C. De Simone,et al. Human eosinophils and parasitic diseases. II. Characterization of two cell fractions isolated at different densities. , 1982, Clinical and experimental immunology.
[15] S. Broder,et al. Metabolic heterogeneity of eosinophils from normal and hypereosinophilic patients. , 1981, Blood.
[16] T. Maciag,et al. Serial propagation of human endothelial cells in vitro , 1981, The Journal of cell biology.
[17] James R. Smith,et al. Expression of angiotensin‐converting enzyme activity in cultured pulmonary artery endothelial cells , 1981, Journal of cellular physiology.
[18] P. Quesenberry,et al. Vascular endothelium as a regulator of granulopoiesis: production of colony-stimulating activity by cultured human endothelial cells. , 1980, Blood.
[19] R. Ross,et al. An endothelial cell-derived growth factor , 1980, The Journal of cell biology.
[20] M. Vadas,et al. A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. , 1979, Journal of immunology.
[21] S. A. Cruise,et al. Isolation and primary culture of endothelial cells from human umbilical vessels , 1978 .
[22] A. Sher,et al. Eosinophils as mediators of antibody-dependent damage to schistosomula , 1975, Nature.
[23] H. Mita,et al. Release of leukotriene C4 from human eosinophils and its relation to the cell density. , 1985, International archives of allergy and applied immunology.
[24] A. Capron,et al. Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. , 1983, International archives of allergy and applied immunology.